Kent Edward Kester
CIK: 0002087469
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TTRX
Turn Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Kester Kent Edward
Kester Kent Edward (SEC CIK 0002087469) files insider reports with the SEC as Director of Turn Therapeutics Inc. (TTRX).
Signal8 holds 3 ownership filings by Kester Kent Edward (1 Form 3, 2 Form 4), filed between Oct 7, 2025 and Jun 8, 2026. Those filings report 2 transactions, from Oct 8, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kester Kent Edward's filings is in WESTLAKE VILLAGE, CA.
Recent filings by Kester Kent Edward
Other insiders filing for Turn Therapeutics Inc. (TTRX)
- Dewhurst Martin William, Director
- Gengos Andrew, Director
- GOLDEN ARTHUR F, Director
- Burnam Bradley Evan, Chief Executive Officer
- Chaudhary Zuraiz
- Chesed Abraham, Officer